Chemomab Therapeutics Files Q2 2026 Results and Updates SEC RegistrationsTip Ranks·Aug 19 at 08:48 AMCMMB+4.35%
Chemomab Therapeutics Announces Second Quarter 2026 Financial Results and Provides Corporate Update | CMMB Stock NewsStockTitan·Aug 18 at 11:26 PMCMMB+4.35%
Weekly Buzz: JNJ, VERA Get FDA Nod; VRTX Snaps Up CRNX; MSLE Aces DMD Trial; IONS Misses Key Goalrttnews·Jul 10 at 11:15 AMABBV+1.20%VANI-2.13%
12 Health Care Stocks Moving In Wednesday's Intraday Sessionbenzinga_article·Jul 8 at 12:05 PMCUPR+1.95%TVRD+1.64%
Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis | CMMB Stock NewsStockTitan·Jul 7 at 10:35 PMCMMB+4.35%
U.S. stock market midday update: Chemomab down 22.45%, merger secures $30 million in financingPrice Alert·Jul 8 at 09:42 AMCMMB+4.35%
Chemomab Therapeutics: Merger creates an AI-powered precision medicine leader advancing nebokitug for RA with $30M fundingQuartr·Jul 8 at 07:17 AMCMMB+4.35%
